Posted by Michael Wonder on 24 Jan 2019
Big pharma spends record millions on lobbying amid pressure to lower drug prices
23 January 2019 - The lobbying group for the pharmaceutical industry spent about $27.5 million on lobbying activities in 2018, federal filings show.
This is a record annual total for the Pharmaceutical Research & Manufacturers of America, or PhRMA, which represents most of the nation's largest drug and biopharmaceutical research companies, including Pfizer, Sanofi, Merck, Johnson & Johnson and Gilead Sciences.
PhRMA's previous record lobbying bill topped out at just over $25 million when the industry fought the Affordable Care Act in 2009.
